The Presence of Activated CD4+ T Cells Is Essential for the Formation of Colony-Forming Unit-Endothelial Cells by CD14+ Cells

The number of colony forming unit-endothelial cells (CFU-EC) in human peripheral blood was found to be a biological marker for several vascular diseases. In this study, the heterogeneous composition of immune cells in the CFU-ECs was investigated. We confirmed that monocytes are essential for the formation of CFU-ECs. Also, however, CD4+ T cells were found to be indispensable for the induction of CFU-EC colonies, mainly through cell-cell contact. By blocking or activating CD3 receptors on CD4+ T cells or blocking MHC class II molecules on monocytes, it was shown that TCR-MHCII interactions are required for induction of CFU-EC colonies. Because the supernatant from preactivated T cells could also induce colony formation from purified monocytes, the T cell support turned out to be cytokine mediated. Gene expression analysis of the endothelial-like colonies formed by CD14+ cells showed that colony formation is a proangiogenic differentiation and might reflect the ability of monocytes to facilitate vascularization. This in vitro study is the first to reveal the role of TCR-MHC class II interactions between T cells and monocytes and the subsequent inflammatory response as stimulus of monocytic properties that are associated with vascularization.

[1]  P. Eilers,et al.  Natural Killer Cells and CD4+ T-Cells Modulate Collateral Artery Development , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[2]  A. Reinisch,et al.  Immune Cells Mimic the Morphology of Endothelial Progenitor Colonies In Vitro , 2007, Stem cells.

[3]  M. Yoder,et al.  Working hypothesis to redefine endothelial progenitor cells , 2007, Leukemia.

[4]  Raquel Soares,et al.  Angiogenesis and chronic inflammation: cause or consequence? , 2007, Angiogenesis.

[5]  J. Prchal,et al.  Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. , 2007, Blood.

[6]  B. Blanco,et al.  Short-term endothelial progenitor cell colonies are composed of monocytes and do not acquire endothelial markers. , 2007, Cytotherapy.

[7]  L. Rink,et al.  The superantigen staphylococcal enterotoxin A (SEA) and monoclonal antibody L243 share a common epitope but differ in their ability to induce apoptosis via MHC-II. , 2006, Immunobiology.

[8]  P. Palange,et al.  Circulating haemopoietic and endothelial progenitor cells are decreased in COPD , 2006, European Respiratory Journal.

[9]  D. Strunk,et al.  Blood Monocytes Mimic Endothelial Progenitor Cells , 2006, Stem cells.

[10]  D. Noonan,et al.  Tumor inflammatory angiogenesis and its chemoprevention. , 2005, Cancer research.

[11]  A. Quyyumi,et al.  Increased circulating endothelial progenitor cells are associated with survival in acute lung injury. , 2005, American journal of respiratory and critical care medicine.

[12]  J. Smolen,et al.  Depletion of Endothelial Progenitor Cells in the Peripheral Blood of Patients With Rheumatoid Arthritis , 2005, Circulation.

[13]  L. Tavazzi,et al.  Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. , 2005, Blood.

[14]  R. Ferrari,et al.  CD34+ and Endothelial Progenitor Cells in Patients With Various Degrees of Congestive Heart Failure , 2004, Circulation.

[15]  T. Asahara,et al.  Endothelial progenitor cells for postnatal vasculogenesis. , 2004, American journal of physiology. Cell physiology.

[16]  S. Dimmeler,et al.  Endothelial Progenitor Cells: Characterization and Role in Vascular Biology , 2004, Circulation research.

[17]  I. Cohen,et al.  Angiogenesis-Inflammation Cross-Talk: Vascular Endothelial Growth Factor Is Secreted by Activated T Cells and Induces Th1 Polarization , 2004, The Journal of Immunology.

[18]  H. Miller,et al.  Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation. , 2004, European heart journal.

[19]  R. Ferrari,et al.  CD 34 and Endothelial Progenitor Cells in Patients With Various Degrees of Congestive Heart Failure , 2004 .

[20]  F. Watzinger,et al.  Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer program , 2003, Leukemia.

[21]  A. la Sala,et al.  Impaired Arteriogenic Response to Acute Hindlimb Ischemia in CD4-Knockout Mice , 2003, Circulation.

[22]  A. Quyyumi,et al.  Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. , 2003, The New England journal of medicine.

[23]  Christie M. Orschell,et al.  Peripheral Blood “Endothelial Progenitor Cells” Are Derived From Monocyte/Macrophages and Secrete Angiogenic Growth Factors , 2003, Circulation.

[24]  A. Cope.  Studies of T-cell activation in chronic inflammation , 2002, Arthritis research.

[25]  G. Panayi,et al.  Cytokine pathways and joint inflammation in rheumatoid arthritis. , 2001, The New England journal of medicine.

[26]  W. Daniel,et al.  Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions. , 2001, Cardiovascular research.

[27]  P. Delves,et al.  The Immune System , 2000 .

[28]  F. C. Lucibello,et al.  Endothelial-like cells derived from human CD14 positive monocytes. , 2000, Differentiation; research in biological diversity.

[29]  P. Carmeliet.  Mechanisms of angiogenesis and arteriogenesis , 2000, Nature Medicine.

[30]  J. Isner,et al.  Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice. , 1999, Circulation.

[31]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[32]  S. Soker,et al.  Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. , 1995, Cancer research.

[33]  T. Eberlein,et al.  T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: a potential pathologic role. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[34]  R. V. van Lier,et al.  Functional studies with anti-CD3 heavy chain isotype switch-variant monoclonal antibodies. Accessory cell-independent induction of interleukin 2 responsiveness in T cells by epsilon-anti-CD3. , 1987, Journal of immunology.

[35]  R. V. van Lier,et al.  Induction of T cell proliferation with anti‐CD3 switch‐variant monoclonal antibodies: effects of heavy chain isotype in monocyte‐dependent systems , 1987, European journal of immunology.

[36]  D. H. Mellor,et al.  Real time , 1981 .

[37]  L. Lampson,et al.  Two populations of Ia-like molecules on a human B cell line. , 1980, Journal of immunology.